Lung cancer is often asymptomatic or causes only nonspecific symptoms in its early stages. Early detection represents one of the most promising approaches to reduce the growing lung cancer burden. Human saliva is an attractive diagnostic fluid because its collection is less invasive than that of tissue or blood. Profiling of proteins in saliva over the course of disease progression could reveal potential biomarkers indicative of oral or systematic diseases, which may be used extensively in future medical diagnostics. There were 72 subjects enrolled in this study for saliva sample collection according to the approved protocol. Two-dimensional difference gel electrophoresis combined with MS was the platform for salivary proteome separation, quantification, and identification from two pooled samples. Candidate proteomic biomarkers were verified and prevalidated by using immunoassay methods. There were 16 candidate protein biomarkers discovered by two-dimensional difference gel electrophoresis and MS. Three proteins were further verified in the discovery sample set, prevalidation sample set, and lung cancer cell lines. The discriminatory power of these candidate biomarkers in lung cancer patients and healthy control subjects can reach 88.5% sensitivity and 92.3% specificity with AUC ؍ 0.90. This preliminary data report demonstrates that proteomic biomarkers are present in human saliva when people develop lung cancer. The discriminatory power of these candidate biomarkers indicate that a simple saliva test might be established for lung cancer clinical screening and detection. Molecular & Cellular Proteomics 11: 10.1074/mcp.M111.012112, 1-12, 2012.Lung cancer has long been a significant worldwide public health issue. In the United States, lung cancer is the most common cause of cancer-related death in men and women. According to the American Cancer Society, the major type of lung cancer is non-small-cell lung cancer (NSCLC) 1 , which comprises ϳ85% of lung cancers (1, 2). Small cell lung cancer (SCLC) is another type of lung cancer, which represents about 15% of cases (3). Cigarette smoking causes lung cancer, which is by far the major risk factor (4, 5, 6). Lung cancer has a high mortality rate among malignancies, in part because symptoms are frequently absent until disease is already metastatic and is, therefore, incurable (7,8,9). Early detection represents a very promising approach to reduce lung cancer incidence and mortality. However, conventional diagnostic methods for lung cancer are unsuitable for widespread screening because they are either expensive and occasionally miss tumors or invasive cancer (10,11,12,13). Computed tomography has been wildly used for lung cancer early screening, although it often produces a high rate of false positives (7,14,15). Better diagnostic methods are urgently needed to improve the detection of lung cancer.Tissue and blood have been extensively used in attempts to detect lung cancer earlier (1,16,17,18). Sputum has also been used to predict lung cancer by detecting its aberra...